Page last updated: 2024-11-10

6-oxopiperidine-2-carboxylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-oxopiperidine-2-carboxylic acid: associated with penicillin V from Penicillium chrysogenum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

6-ketopiperidine-2-carboxylic acid : A delta-lactam that is piperidine-2-carboxylic acid substituted at position 6 by an oxo group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3014237
CHEMBL ID4648450
CHEBI ID87998
SCHEMBL ID630497
SCHEMBL ID23002168
MeSH IDM0097425

Synonyms (38)

Synonym
6-oxo-2-piperidinecarboxylic acid
adipo-2,6-lactam
AB53F804-EF6B-4877-928C-B8B94C16F6CC
3770-22-7
6-oxopiperidine-2-carboxylic acid
6-oxo-pipecolinic acid
6-oxo-piperidine-2-carboxylic acid
6-oxopipecolinic acid
6-oxo-piperidine-2-carboxylicacid
6-oxopiperidine-2-carboxylic acid;6-oxo-pipecolinic acid
2-piperidinecarboxylic acid, 6-oxo-
FT-0635014
FT-0600769
AB16268
AKOS015856193
SCHEMBL630497
FZXCPFJMYOQZCA-UHFFFAOYSA-N
AB49077
CS-0099890
cyclic alpha-aminoadipic acid
CHEBI:87998
6-ketopiperidine-2-carboxylic acid
mfcd03839863
mfcd06796545
6-oxo-pipecolinic acid, aldrichcpr
SCHEMBL23002168
ZB0735
Q27160012
SY238900
FT-0770563
AS-35402
AMY18113
EN300-113247
6-hydroxy-2,3,4,5-tetrahydropyridine-2-carboxylic acid
DTXSID00958739
5-(4-methyl-2-nitro-phenyl)-furan-2-carboxylicacid
SB41315
CHEMBL4648450
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
delta-lactamA lactam in which the amide bond is contained within a six-membered ring, which includes the amide nitrogen and the carbonyl carbon.
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1666384Inhibition of human P2X7 expressed in human HEK293 cells assessed as reduction in BzATP-stimulated TO-PRO-3 incorporation at 10 uM preincubated with compound and TO-PRO-3 for 15 mins prior to BzATP addition and measured after 1 hr by Fluo-3AM dye based fl2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.81 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]